In contrast, samples carrying any of the four other frequently mutated genes in ccRCC segregated equally between both groups (BAP1) or mainly in the ‘low read-through’ category (VHL, PBRM1, MTOR. This evidence concerns the gene MTOR and nonpapillary renal cell carcinoma.